|
LMAN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.515800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.246000E-01 |
| Normal-vs-Stage2 |
1.702640E-01 |
| Normal-vs-Stage3 |
8.859800E-01 |
| Normal-vs-Stage4 |
9.596000E-01 |
| Stage1-vs-Stage2 |
4.266800E-01 |
| Stage1-vs-Stage3 |
1.921400E-01 |
| Stage1-vs-Stage4 |
3.448000E-01 |
| Stage2-vs-Stage3 |
1.545800E-01 |
| Stage2-vs-Stage4 |
2.108600E-01 |
| Stage3-vs-Stage4 |
8.651000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.671420E-01 |
| Normal-vs-AfricanAmerican |
1.838020E-03 |
| Normal-vs-Asian |
6.756600E-01 |
| Caucasian-vs-AfricanAmerican |
3.09409999954546E-07 |
| Caucasian-vs-Asian |
7.958200E-01 |
| AfricanAmerican-vs-Asian |
2.925400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.129000E-01 |
| Normal-vs-Female |
2.555600E-01 |
| Male-vs-Female |
4.985800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.723400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.641000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.545800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.694000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.190800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.729600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.061600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.204400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.431800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.467400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.504300E-02 |
| Normal-vs-Grade 2 |
4.841500E-02 |
| Normal-vs-Grade 3 |
9.618200E-01 |
| Normal-vs-Grade 4 |
2.899800E-01 |
| Grade 1-vs-Grade 2 |
6.012600E-01 |
| Grade 1-vs-Grade 3 |
1.108020E-01 |
| Grade 1-vs-Grade 4 |
6.206000E-02 |
| Grade 2-vs-Grade 3 |
2.153900E-02 |
| Grade 2-vs-Grade 4 |
1.265990E-02 |
| Grade 3-vs-Grade 4 |
2.421400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.568000E-04 |
| Normal-vs-ccB subtype |
8.357400E-01 |
| ccA subtype-vs-ccB subtype |
1.835240E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.654200E-01 |
| Normal-vs-N1 |
5.114400E-01 |
| N0-vs-N1 |
6.833200E-01 |
|
|
